oxybutynin has been researched along with Myelodysplastic Syndromes in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zama, D | 1 |
| Masetti, R | 1 |
| Vendemini, F | 1 |
| Di Donato, F | 1 |
| Morelli, A | 1 |
| Prete, A | 1 |
| Pession, A | 1 |
1 other study available for oxybutynin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients.
Topics: Child; Cystitis; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Hyperbaric Oxy | 2013 |